Mayo Clinic Hepato-Pancreatico-Biliary Cancer Symposium 2025 - Livestream (virtual)

November 7, 2025 to November 8, 2025

Course Directors - Tanios S. Bekaii-Saab, M.D., Mitesh J. Borad, M.D., G. Dan Duda, D.M.D., Ph.D., and Mark J. Truty, M.D., M.S.

November 7 - 8, 2025 - Internet Live Activity - Las Vegas, Nevada
Broadcast in Pacific Time

The 2025 Mayo Clinic Hepato-Pancreatico-Biliary Cancer Symposium provides a multidisciplinary overview of the importance of early diagnosis and treatment considerations, including surgery, radiation, loco-regional approaches, and systemic therapies. Nationally and internationally renowned faculty offer state-of-the-art updates on current treatment options for patients with hepato-pancreatico-biliary cancers. This timely education is delivered through case-based discussions, interactive Q&A, and didactic presentations. The target audience for this activity includes physicians and allied health professionals.

 

Target Audience

This course is intended for surgeons, gastroenterologists, medical and radiation oncologists, laboratory scientists, and allied health professionals in the following specialties: medical oncology, hematology, gastroenterology, radiation oncology, surgical oncology, pathology, radiology, and laboratory research science.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the role of transarterial chemoembolization (TACE) as the standard treatment approach for intermediate-stage hepatocellular carcinoma (HCC)
  • Evaluate the role of surveillance in the management of hepatic adenomas and adenomatosis
  • Review the current landscape of immuno-oncology (IO)–based therapies approved for advanced-stage hepatocellular carcinoma (HCC)
  • Identify key molecular alterations in biliary tract malignancies for targeted therapy
  • Evaluate current NCCN resectability criteria for pancreatic ductal adenocarcinoma (PDAC)
  • Identify appropriate patient selection criteria for neoadjuvant CAP/TEM therapy in locally advanced PNETs
  • Describe strategies for managing high biologic risk pancreatic ductal adenocarcinoma (PDAC)
     

Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.

Course summary
Available credit: 
  • 11.50 AAPA Category 1
  • 11.50 ABS
  • 11.50 AMA PRA Category 1 Credit™
  • 11.50 ANCC
  • 11.50 Attendance
Event starts: 
11/07/2025 - 7:00am
Event ends: 
11/08/2025 - 1:00pm
Cost:
$625.00
Part of: 
Mayo Clinic Hepato-Pancreatico-Biliary Cancer Symposium 2025

Click here to view Program Schedule on mobile


 
Internet Live Activity
Las Vegas, NV 89109
United States

Broadcast in Pacific Time
All travel and lodging expenses are the sole responsibility of the individual registrant.

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Credit Statement(s):

AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 11.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA
Mayo Clinic College of Medicine and Science has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. Approval is valid until 11/8/2025. This activity is designated for 11.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

ANCC
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 11.50 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Surgery (ABS)
Successful completion of this CME activity enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Other Healthcare Professionals:
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Available Credit

  • 11.50 AAPA Category 1
  • 11.50 ABS
  • 11.50 AMA PRA Category 1 Credit™
  • 11.50 ANCC
  • 11.50 Attendance

For information regarding exhibit opportunities, please reach out to Kristy Badder.

Price

Cost:
$625.00
Please login or register to take this course.

Broadcast in Pacific Time
To claim credit for livestream participation in this course, learners must view the content during the hours posted for the live activity. This course is not approved for on-demand delivery.

Commitment to Belonging and Inclusion

Mayo Clinic School of Continuous Professional Development (MCSCPD) strives to foster a learning environment in which all individuals are valued, allowing all to achieve their fullest potential.

Cancellation and Refund Policy

View Cancellation and Refund Policy

All requests must be submitted in writing using the Contact Us Form.

Any use of this site constitutes your agreement to the Terms and Conditions of Registration.